Interview filmed with Dr Hermann Einsele, Director of the Department of Internal Medicine II at the Würzburg University Hospital, Germany, to summarise the results of the clinical trial CARTITUDE-4, presented ...at European Hematology Association’s annual congress (EHA 2023 Virtual), held in June 2023. This trial evaluates the CAR-T treatment cilta-cel versus standard of care (PVD or DPD) in lenalidomide-refractory myeloma patients.[+] Show More
active
Interview filmed with Dr Hermann Einsele, Director of the Department ...
Interview filmed with Dr Hermann Einsele, Director of the Department of Internal Medicine II at the Würzburg University Hospital, Germany, to summarise the results of the clinical trial CARTITUDE-4, presented ...at European Hematology Association’s annual congress (EHA 2023 Virtual), held in June 2023. This trial evaluates the CAR-T treatment cilta-cel versus standard of care (PVD or DPD) in lenalidomide-refractory myeloma patients.[+] Show More
active
Prof. Monique Minnema, internist and haematologist at Academic Medical ...
Prof. Monique Minnema, internist and haematologist at Academic Medical Center, Amsterdam and the University Medical Center, Utrecht, The Netherlands, summarise in this interview the results of the clinical trial MonumenTAL-1, ...presented at EHA 2023. The phase I/II MonumenTAL-1 trial evaluates talquetamab in patients with relapsed/refractory myeloma.[+] Show More
active
Interview filmed with Dr María Victoria Mateos, Director of the ...
Interview filmed with Dr María Victoria Mateos, Director of the Myeloma Unit at the University Hospital of Salamanca-IBSAL in Spain, to summarise the results of the clinical trial Redirectt-1, presented ...at European Hematology Association’s annual congress (EHA 2023 Virtual), held in June 2023. This trial analyses the efficacy of teclistamab and talquetamab simultaneously in relapsed or refractory myeloma patients.[+] Show More
active
Interview filmed with Dr. Efstathios Kastritis, Associate Professor at ...
Interview filmed with Dr. Efstathios Kastritis, Associate Professor at the National and Kapodistrian University of Athens, Greece, to summarise the results of the clinical trial EMN 27, presented at European ...Hematology Association’s annual congress (EHA 2023 Virtual), held in June 2023.[+] Show More
active
Prof. Dr. Mohamad Mohty, Professor and Head of the hematology and ...
Prof. Dr. Mohamad Mohty, Professor and Head of the hematology and cellular therapy department at the Saint-Antoine Hospital in Paris, France, explains the latest MagnetisMM-3 clinical trial information at the ...European Hematology Association hybrid congress 2023. This clinical trial tests the efficacy of elranatamab in relapsed and refractory myeloma.[+] Show More
active
Prof. Dr. Ibrahim Yakoub-Agha, Head of the Hematopoietic Cell ...
Prof. Dr. Ibrahim Yakoub-Agha, Head of the Hematopoietic Cell Transplantation Unit at Lille University Hospital, explains the safety updates.
The video is in French.
active
Prof. Dr. Ibrahim Yakoub-Agha, Head of the Hematopoietic Cell ...
Prof. Dr. Ibrahim Yakoub-Agha, Head of the Hematopoietic Cell Transplantation Unit at Lille University Hospital, explains the safety updates.
The video is in English.
active
Dr. Bruno Paiva, Scientific Coordinator of the Diagnostic Laboratories ...
Dr. Bruno Paiva, Scientific Coordinator of the Diagnostic Laboratories of the University of Navarra (Spain), explains what immune monitoring is.
The video is in Spanish.
active
Dr. Bruno Paiva, Scientific Coordinator of the Diagnostic Laboratories ...
Dr. Bruno Paiva, Scientific Coordinator of the Diagnostic Laboratories of the University of Navarra (Spain), explains what immune monitoring is.
The video is in English.
active
Prof. Dr. Halvard B. Bönig, Research and Development Department ...
Prof. Dr. Halvard B. Bönig, Research and Development Department Translational Cell Therapy Development/GMP, explains the manufacturing process of the CARAMBA CAR-T treatment.
The interview is in German.
active
Prof. Dr. Halvard B. Bönig, Research and Development Department ...
Prof. Dr. Halvard B. Bönig, Research and Development Department Translational Cell Therapy Development/GMP, explains the manufacturing process of the CARAMBA CAR-T treatment.
The interview is in English.
active
In this video, Dr Sonja Zweegman, Amsterdam University Medical ...
In this video, Dr Sonja Zweegman, Amsterdam University Medical Centers, Cancer Centers Amsterdam, the Netherlands, and member of the Myeloma Patients Europe (MPE) Medical Advisory Committee, explains the updates for ...frail and high-risk patients presented at ASH 2022.[+] Show More
